Your browser doesn't support javascript.
loading
HDAC inhibitors enhance the anti-tumor effect of immunotherapies in hepatocellular carcinoma.
Shen, Chen; Li, Mei; Duan, Yujuan; Jiang, Xin; Hou, Xiaoming; Xue, Fulai; Zhang, Yinan; Luo, Yao.
Affiliation
  • Shen C; Department of Laboratory Medicine, Medical Equipment Innovation Research Center/Medical Device Regulatory Research and Evaluation Center, West China Hospital, Sichuan University, Chengdu, China.
  • Li M; Department of Laboratory Medicine, Medical Equipment Innovation Research Center/Medical Device Regulatory Research and Evaluation Center, West China Hospital, Sichuan University, Chengdu, China.
  • Duan Y; School of Chemical Science and Engineering, Tongji University, Shanghai, China.
  • Jiang X; School of Chemistry and Chemical Engineering, Shanghai Jiao Tong University, Shanghai, China.
  • Hou X; Department of Laboratory Medicine, Medical Equipment Innovation Research Center/Medical Device Regulatory Research and Evaluation Center, West China Hospital, Sichuan University, Chengdu, China.
  • Xue F; Department of Laboratory Medicine, Medical Equipment Innovation Research Center/Medical Device Regulatory Research and Evaluation Center, West China Hospital, Sichuan University, Chengdu, China.
  • Zhang Y; Department of Laboratory Medicine, Medical Equipment Innovation Research Center/Medical Device Regulatory Research and Evaluation Center, West China Hospital, Sichuan University, Chengdu, China.
  • Luo Y; School of Chemical Science and Engineering, Tongji University, Shanghai, China.
Front Immunol ; 14: 1170207, 2023.
Article in En | MEDLINE | ID: mdl-37304265
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Hepatocellular / Liver Neoplasms Limits: Humans Language: En Journal: Front Immunol Year: 2023 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Hepatocellular / Liver Neoplasms Limits: Humans Language: En Journal: Front Immunol Year: 2023 Document type: Article